nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—pancreatic cancer—adrenal gland cancer	0.378	0.544	CtDrD
Sunitinib—kidney cancer—adrenal gland cancer	0.317	0.456	CtDrD
Sunitinib—ABCB1—adrenal gland cancer	0.069	1	CbGaD
Sunitinib—CLK2—adrenal cortex—adrenal gland cancer	0.000322	0.00329	CbGeAlD
Sunitinib—STK38—pituitary gland—adrenal gland cancer	0.000321	0.00328	CbGeAlD
Sunitinib—RPS6KA2—pituitary gland—adrenal gland cancer	0.000321	0.00328	CbGeAlD
Sunitinib—BRD4—adrenal gland—adrenal gland cancer	0.000319	0.00326	CbGeAlD
Sunitinib—STK11—adrenal gland—adrenal gland cancer	0.000319	0.00326	CbGeAlD
Sunitinib—PRPF4—gonad—adrenal gland cancer	0.000319	0.00326	CbGeAlD
Sunitinib—PRPF4—cardiac atrium—adrenal gland cancer	0.000319	0.00325	CbGeAlD
Sunitinib—STK3—adrenal cortex—adrenal gland cancer	0.000316	0.00323	CbGeAlD
Sunitinib—PKN1—pituitary gland—adrenal gland cancer	0.000316	0.00323	CbGeAlD
Sunitinib—CSNK1G2—pituitary gland—adrenal gland cancer	0.000316	0.00323	CbGeAlD
Sunitinib—RPS6KA1—adrenal gland—adrenal gland cancer	0.000316	0.00322	CbGeAlD
Sunitinib—RIOK1—adrenal gland—adrenal gland cancer	0.000316	0.00322	CbGeAlD
Sunitinib—PRPF4B—gonad—adrenal gland cancer	0.000315	0.00321	CbGeAlD
Sunitinib—PRPF4B—cardiac atrium—adrenal gland cancer	0.000314	0.00321	CbGeAlD
Sunitinib—PRPF4—pituitary gland—adrenal gland cancer	0.000311	0.00318	CbGeAlD
Sunitinib—STK39—gonad—adrenal gland cancer	0.00031	0.00317	CbGeAlD
Sunitinib—STK39—cardiac atrium—adrenal gland cancer	0.00031	0.00316	CbGeAlD
Sunitinib—TNIK—adrenal gland—adrenal gland cancer	0.00031	0.00316	CbGeAlD
Sunitinib—MARK2—adrenal gland—adrenal gland cancer	0.00031	0.00316	CbGeAlD
Sunitinib—PRPF4B—pituitary gland—adrenal gland cancer	0.000307	0.00313	CbGeAlD
Sunitinib—SGK3—adrenal gland—adrenal gland cancer	0.000307	0.00313	CbGeAlD
Sunitinib—CSNK2A1—gonad—adrenal gland cancer	0.000306	0.00313	CbGeAlD
Sunitinib—CSNK2A1—cardiac atrium—adrenal gland cancer	0.000306	0.00312	CbGeAlD
Sunitinib—ICK—adrenal gland—adrenal gland cancer	0.000304	0.0031	CbGeAlD
Sunitinib—STK39—pituitary gland—adrenal gland cancer	0.000303	0.00309	CbGeAlD
Sunitinib—MYLK—gonad—adrenal gland cancer	0.000302	0.00309	CbGeAlD
Sunitinib—MYLK—cardiac atrium—adrenal gland cancer	0.000302	0.00308	CbGeAlD
Sunitinib—CSNK2A1—pituitary gland—adrenal gland cancer	0.000299	0.00305	CbGeAlD
Sunitinib—PLK4—gonad—adrenal gland cancer	0.000298	0.00305	CbGeAlD
Sunitinib—MERTK—adrenal cortex—adrenal gland cancer	0.000297	0.00304	CbGeAlD
Sunitinib—CHEK2—adrenal gland—adrenal gland cancer	0.000294	0.003	CbGeAlD
Sunitinib—NUAK1—adrenal gland—adrenal gland cancer	0.000294	0.003	CbGeAlD
Sunitinib—PHKG2—gonad—adrenal gland cancer	0.000291	0.00298	CbGeAlD
Sunitinib—OXSR1—adrenal gland—adrenal gland cancer	0.000291	0.00297	CbGeAlD
Sunitinib—SNRK—adrenal gland—adrenal gland cancer	0.000291	0.00297	CbGeAlD
Sunitinib—INSR—adrenal gland—adrenal gland cancer	0.000291	0.00297	CbGeAlD
Sunitinib—MAP3K12—adrenal cortex—adrenal gland cancer	0.000288	0.00294	CbGeAlD
Sunitinib—RPS6KA2—adrenal gland—adrenal gland cancer	0.000287	0.00293	CbGeAlD
Sunitinib—STK38—adrenal gland—adrenal gland cancer	0.000287	0.00293	CbGeAlD
Sunitinib—DAPK2—cardiac atrium—adrenal gland cancer	0.000286	0.00292	CbGeAlD
Sunitinib—AURKC—adrenal gland—adrenal gland cancer	0.000284	0.0029	CbGeAlD
Sunitinib—RPS6KA3—adrenal cortex—adrenal gland cancer	0.000284	0.0029	CbGeAlD
Sunitinib—STK24—pituitary gland—adrenal gland cancer	0.000283	0.00289	CbGeAlD
Sunitinib—PKN1—adrenal gland—adrenal gland cancer	0.000282	0.00288	CbGeAlD
Sunitinib—CSNK1G2—adrenal gland—adrenal gland cancer	0.000282	0.00288	CbGeAlD
Sunitinib—TYRO3—gonad—adrenal gland cancer	0.00028	0.00286	CbGeAlD
Sunitinib—HIPK3—gonad—adrenal gland cancer	0.00028	0.00286	CbGeAlD
Sunitinib—HIPK2—gonad—adrenal gland cancer	0.00028	0.00286	CbGeAlD
Sunitinib—HIPK3—cardiac atrium—adrenal gland cancer	0.00028	0.00286	CbGeAlD
Sunitinib—CSNK1A1—adrenal cortex—adrenal gland cancer	0.000278	0.00284	CbGeAlD
Sunitinib—PRPF4—adrenal gland—adrenal gland cancer	0.000278	0.00284	CbGeAlD
Sunitinib—RIOK2—cardiac atrium—adrenal gland cancer	0.000277	0.00283	CbGeAlD
Sunitinib—CLK1—adrenal cortex—adrenal gland cancer	0.000277	0.00282	CbGeAlD
Sunitinib—STK16—pituitary gland—adrenal gland cancer	0.000275	0.00281	CbGeAlD
Sunitinib—PRPF4B—adrenal gland—adrenal gland cancer	0.000274	0.0028	CbGeAlD
Sunitinib—HIPK3—pituitary gland—adrenal gland cancer	0.000274	0.00279	CbGeAlD
Sunitinib—ALK—pituitary gland—adrenal gland cancer	0.000274	0.00279	CbGeAlD
Sunitinib—TNK1—pituitary gland—adrenal gland cancer	0.000271	0.00276	CbGeAlD
Sunitinib—RIOK2—pituitary gland—adrenal gland cancer	0.000271	0.00276	CbGeAlD
Sunitinib—STK39—adrenal gland—adrenal gland cancer	0.00027	0.00276	CbGeAlD
Sunitinib—DAPK3—cardiac atrium—adrenal gland cancer	0.000269	0.00275	CbGeAlD
Sunitinib—CLK2—gonad—adrenal gland cancer	0.000267	0.00272	CbGeAlD
Sunitinib—CSNK2A1—adrenal gland—adrenal gland cancer	0.000267	0.00272	CbGeAlD
Sunitinib—CLK2—cardiac atrium—adrenal gland cancer	0.000266	0.00272	CbGeAlD
Sunitinib—MYLK—adrenal gland—adrenal gland cancer	0.000263	0.00269	CbGeAlD
Sunitinib—DAPK3—pituitary gland—adrenal gland cancer	0.000263	0.00268	CbGeAlD
Sunitinib—FLT4—adrenal cortex—adrenal gland cancer	0.000261	0.00267	CbGeAlD
Sunitinib—CLK2—pituitary gland—adrenal gland cancer	0.00026	0.00266	CbGeAlD
Sunitinib—PLK4—adrenal gland—adrenal gland cancer	0.00026	0.00266	CbGeAlD
Sunitinib—MAP4K2—pituitary gland—adrenal gland cancer	0.000259	0.00265	CbGeAlD
Sunitinib—ROCK1—gonad—adrenal gland cancer	0.000259	0.00264	CbGeAlD
Sunitinib—STK4—adrenal gland—adrenal gland cancer	0.000259	0.00264	CbGeAlD
Sunitinib—CSNK1E—adrenal cortex—adrenal gland cancer	0.000258	0.00263	CbGeAlD
Sunitinib—STK3—pituitary gland—adrenal gland cancer	0.000256	0.00261	CbGeAlD
Sunitinib—PHKG2—adrenal gland—adrenal gland cancer	0.000254	0.00259	CbGeAlD
Sunitinib—IRAK4—adrenal cortex—adrenal gland cancer	0.000254	0.00259	CbGeAlD
Sunitinib—STK24—adrenal gland—adrenal gland cancer	0.000253	0.00258	CbGeAlD
Sunitinib—DYRK1A—gonad—adrenal gland cancer	0.000252	0.00258	CbGeAlD
Sunitinib—DAPK2—adrenal gland—adrenal gland cancer	0.00025	0.00255	CbGeAlD
Sunitinib—ULK3—adrenal cortex—adrenal gland cancer	0.000248	0.00253	CbGeAlD
Sunitinib—STK16—adrenal gland—adrenal gland cancer	0.000246	0.00251	CbGeAlD
Sunitinib—HIPK2—adrenal gland—adrenal gland cancer	0.000244	0.00249	CbGeAlD
Sunitinib—HIPK3—adrenal gland—adrenal gland cancer	0.000244	0.00249	CbGeAlD
Sunitinib—MAP3K7—adrenal cortex—adrenal gland cancer	0.000244	0.00249	CbGeAlD
Sunitinib—TNK1—adrenal gland—adrenal gland cancer	0.000242	0.00247	CbGeAlD
Sunitinib—RIOK2—adrenal gland—adrenal gland cancer	0.000242	0.00247	CbGeAlD
Sunitinib—MAP4K4—gonad—adrenal gland cancer	0.000242	0.00247	CbGeAlD
Sunitinib—MAP4K4—cardiac atrium—adrenal gland cancer	0.000242	0.00247	CbGeAlD
Sunitinib—TBK1—adrenal cortex—adrenal gland cancer	0.000241	0.00246	CbGeAlD
Sunitinib—MERTK—pituitary gland—adrenal gland cancer	0.00024	0.00245	CbGeAlD
Sunitinib—TYK2—adrenal cortex—adrenal gland cancer	0.00024	0.00245	CbGeAlD
Sunitinib—MAP4K1—adrenal gland—adrenal gland cancer	0.000239	0.00244	CbGeAlD
Sunitinib—FLT3—gonad—adrenal gland cancer	0.000238	0.00243	CbGeAlD
Sunitinib—MAP3K12—gonad—adrenal gland cancer	0.000238	0.00243	CbGeAlD
Sunitinib—MAP3K12—cardiac atrium—adrenal gland cancer	0.000238	0.00243	CbGeAlD
Sunitinib—MAP4K4—pituitary gland—adrenal gland cancer	0.000236	0.00241	CbGeAlD
Sunitinib—RPS6KA3—cardiac atrium—adrenal gland cancer	0.000235	0.0024	CbGeAlD
Sunitinib—DAPK3—adrenal gland—adrenal gland cancer	0.000235	0.0024	CbGeAlD
Sunitinib—NUAK2—pituitary gland—adrenal gland cancer	0.000234	0.00239	CbGeAlD
Sunitinib—MAP2K1—gonad—adrenal gland cancer	0.000234	0.00238	CbGeAlD
Sunitinib—MAP3K12—pituitary gland—adrenal gland cancer	0.000233	0.00237	CbGeAlD
Sunitinib—CLK2—adrenal gland—adrenal gland cancer	0.000233	0.00237	CbGeAlD
Sunitinib—RPS6KB1—adrenal cortex—adrenal gland cancer	0.000232	0.00237	CbGeAlD
Sunitinib—MAP4K2—adrenal gland—adrenal gland cancer	0.000231	0.00236	CbGeAlD
Sunitinib—CSNK1A1—gonad—adrenal gland cancer	0.000231	0.00235	CbGeAlD
Sunitinib—CSNK1A1—cardiac atrium—adrenal gland cancer	0.00023	0.00235	CbGeAlD
Sunitinib—AXL—adrenal cortex—adrenal gland cancer	0.00023	0.00235	CbGeAlD
Sunitinib—RPS6KA3—pituitary gland—adrenal gland cancer	0.000229	0.00234	CbGeAlD
Sunitinib—CLK1—gonad—adrenal gland cancer	0.000229	0.00234	CbGeAlD
Sunitinib—CLK1—cardiac atrium—adrenal gland cancer	0.000229	0.00234	CbGeAlD
Sunitinib—STK3—adrenal gland—adrenal gland cancer	0.000228	0.00233	CbGeAlD
Sunitinib—CSNK1A1—pituitary gland—adrenal gland cancer	0.000225	0.0023	CbGeAlD
Sunitinib—BMP2K—gonad—adrenal gland cancer	0.000225	0.0023	CbGeAlD
Sunitinib—CLK1—pituitary gland—adrenal gland cancer	0.000223	0.00228	CbGeAlD
Sunitinib—LRRK2—gonad—adrenal gland cancer	0.000223	0.00227	CbGeAlD
Sunitinib—SLK—adrenal cortex—adrenal gland cancer	0.000221	0.00226	CbGeAlD
Sunitinib—DYRK1A—adrenal gland—adrenal gland cancer	0.00022	0.00224	CbGeAlD
Sunitinib—CYP3A4—urine—adrenal gland cancer	0.00022	0.00224	CbGeAlD
Sunitinib—PRKAA1—gonad—adrenal gland cancer	0.00022	0.00224	CbGeAlD
Sunitinib—CAMK2G—pituitary gland—adrenal gland cancer	0.000219	0.00224	CbGeAlD
Sunitinib—LRRK2—pituitary gland—adrenal gland cancer	0.000217	0.00222	CbGeAlD
Sunitinib—PTK2B—gonad—adrenal gland cancer	0.000217	0.00222	CbGeAlD
Sunitinib—MERTK—adrenal gland—adrenal gland cancer	0.000215	0.00219	CbGeAlD
Sunitinib—FGFR1—cardiac atrium—adrenal gland cancer	0.000213	0.00218	CbGeAlD
Sunitinib—MAP4K4—adrenal gland—adrenal gland cancer	0.000211	0.00215	CbGeAlD
Sunitinib—MAP3K3—adrenal cortex—adrenal gland cancer	0.00021	0.00215	CbGeAlD
Sunitinib—NUAK2—adrenal gland—adrenal gland cancer	0.000209	0.00214	CbGeAlD
Sunitinib—CSNK1E—pituitary gland—adrenal gland cancer	0.000208	0.00213	CbGeAlD
Sunitinib—FGFR1—pituitary gland—adrenal gland cancer	0.000208	0.00213	CbGeAlD
Sunitinib—MAP3K12—adrenal gland—adrenal gland cancer	0.000208	0.00212	CbGeAlD
Sunitinib—FLT3—adrenal gland—adrenal gland cancer	0.000208	0.00212	CbGeAlD
Sunitinib—MAP2K2—gonad—adrenal gland cancer	0.000206	0.0021	CbGeAlD
Sunitinib—ULK3—gonad—adrenal gland cancer	0.000206	0.0021	CbGeAlD
Sunitinib—ULK3—cardiac atrium—adrenal gland cancer	0.000205	0.0021	CbGeAlD
Sunitinib—MAP2K2—cardiac atrium—adrenal gland cancer	0.000205	0.0021	CbGeAlD
Sunitinib—IRAK4—pituitary gland—adrenal gland cancer	0.000205	0.00209	CbGeAlD
Sunitinib—RPS6KA3—adrenal gland—adrenal gland cancer	0.000205	0.00209	CbGeAlD
Sunitinib—MAP3K2—gonad—adrenal gland cancer	0.000204	0.00208	CbGeAlD
Sunitinib—MAP2K1—adrenal gland—adrenal gland cancer	0.000204	0.00208	CbGeAlD
Sunitinib—FLT1—adrenal cortex—adrenal gland cancer	0.000203	0.00208	CbGeAlD
Sunitinib—MAP3K7—cardiac atrium—adrenal gland cancer	0.000202	0.00206	CbGeAlD
Sunitinib—CSNK1A1—adrenal gland—adrenal gland cancer	0.000201	0.00205	CbGeAlD
Sunitinib—MAP2K2—pituitary gland—adrenal gland cancer	0.000201	0.00205	CbGeAlD
Sunitinib—ULK3—pituitary gland—adrenal gland cancer	0.000201	0.00205	CbGeAlD
Sunitinib—TBK1—gonad—adrenal gland cancer	0.0002	0.00204	CbGeAlD
Sunitinib—TBK1—cardiac atrium—adrenal gland cancer	0.0002	0.00204	CbGeAlD
Sunitinib—CLK1—adrenal gland—adrenal gland cancer	0.0002	0.00204	CbGeAlD
Sunitinib—TYK2—cardiac atrium—adrenal gland cancer	0.000198	0.00202	CbGeAlD
Sunitinib—MAP3K7—pituitary gland—adrenal gland cancer	0.000197	0.00201	CbGeAlD
Sunitinib—BMP2K—adrenal gland—adrenal gland cancer	0.000196	0.002	CbGeAlD
Sunitinib—CAMK2G—adrenal gland—adrenal gland cancer	0.000196	0.002	CbGeAlD
Sunitinib—TBK1—pituitary gland—adrenal gland cancer	0.000195	0.00199	CbGeAlD
Sunitinib—LRRK2—adrenal gland—adrenal gland cancer	0.000194	0.00198	CbGeAlD
Sunitinib—YES1—adrenal cortex—adrenal gland cancer	0.000194	0.00198	CbGeAlD
Sunitinib—TYK2—pituitary gland—adrenal gland cancer	0.000194	0.00198	CbGeAlD
Sunitinib—RPS6KB1—cardiac atrium—adrenal gland cancer	0.000192	0.00196	CbGeAlD
Sunitinib—TAOK3—adrenal cortex—adrenal gland cancer	0.000192	0.00196	CbGeAlD
Sunitinib—PRKAA1—adrenal gland—adrenal gland cancer	0.000191	0.00195	CbGeAlD
Sunitinib—AXL—gonad—adrenal gland cancer	0.00019	0.00194	CbGeAlD
Sunitinib—AXL—cardiac atrium—adrenal gland cancer	0.00019	0.00194	CbGeAlD
Sunitinib—PTK2B—adrenal gland—adrenal gland cancer	0.000189	0.00193	CbGeAlD
Sunitinib—FLT4—adrenal gland—adrenal gland cancer	0.000189	0.00193	CbGeAlD
Sunitinib—RPS6KB1—pituitary gland—adrenal gland cancer	0.000188	0.00192	CbGeAlD
Sunitinib—RET—pituitary gland—adrenal gland cancer	0.000186	0.0019	CbGeAlD
Sunitinib—FGR—pituitary gland—adrenal gland cancer	0.000186	0.0019	CbGeAlD
Sunitinib—CSNK1E—adrenal gland—adrenal gland cancer	0.000186	0.0019	CbGeAlD
Sunitinib—FGFR1—adrenal gland—adrenal gland cancer	0.000186	0.0019	CbGeAlD
Sunitinib—AXL—pituitary gland—adrenal gland cancer	0.000186	0.0019	CbGeAlD
Sunitinib—IRAK4—adrenal gland—adrenal gland cancer	0.000183	0.00187	CbGeAlD
Sunitinib—SLK—cardiac atrium—adrenal gland cancer	0.000183	0.00187	CbGeAlD
Sunitinib—JAK2—gonad—adrenal gland cancer	0.000181	0.00184	CbGeAlD
Sunitinib—JAK2—cardiac atrium—adrenal gland cancer	0.00018	0.00184	CbGeAlD
Sunitinib—MAP2K2—adrenal gland—adrenal gland cancer	0.000179	0.00183	CbGeAlD
Sunitinib—ULK3—adrenal gland—adrenal gland cancer	0.000179	0.00183	CbGeAlD
Sunitinib—SLK—pituitary gland—adrenal gland cancer	0.000179	0.00183	CbGeAlD
Sunitinib—FYN—cardiac atrium—adrenal gland cancer	0.000178	0.00182	CbGeAlD
Sunitinib—MAP3K2—adrenal gland—adrenal gland cancer	0.000178	0.00182	CbGeAlD
Sunitinib—JAK2—pituitary gland—adrenal gland cancer	0.000176	0.0018	CbGeAlD
Sunitinib—MAP3K7—adrenal gland—adrenal gland cancer	0.000176	0.0018	CbGeAlD
Sunitinib—TBK1—adrenal gland—adrenal gland cancer	0.000174	0.00178	CbGeAlD
Sunitinib—MAP3K3—gonad—adrenal gland cancer	0.000174	0.00178	CbGeAlD
Sunitinib—MAP4K5—gonad—adrenal gland cancer	0.000174	0.00178	CbGeAlD
Sunitinib—MAP4K5—cardiac atrium—adrenal gland cancer	0.000174	0.00178	CbGeAlD
Sunitinib—MAP3K3—cardiac atrium—adrenal gland cancer	0.000174	0.00178	CbGeAlD
Sunitinib—FYN—pituitary gland—adrenal gland cancer	0.000174	0.00177	CbGeAlD
Sunitinib—TYK2—adrenal gland—adrenal gland cancer	0.000173	0.00177	CbGeAlD
Sunitinib—KDR—adrenal cortex—adrenal gland cancer	0.000172	0.00175	CbGeAlD
Sunitinib—MAP2K5—adrenal cortex—adrenal gland cancer	0.000172	0.00175	CbGeAlD
Sunitinib—IRAK1—adrenal gland—adrenal gland cancer	0.000171	0.00174	CbGeAlD
Sunitinib—MAP4K5—pituitary gland—adrenal gland cancer	0.00017	0.00173	CbGeAlD
Sunitinib—MAP3K3—pituitary gland—adrenal gland cancer	0.00017	0.00173	CbGeAlD
Sunitinib—FLT1—gonad—adrenal gland cancer	0.000168	0.00172	CbGeAlD
Sunitinib—FLT1—cardiac atrium—adrenal gland cancer	0.000168	0.00172	CbGeAlD
Sunitinib—CSF1R—adrenal cortex—adrenal gland cancer	0.000168	0.00171	CbGeAlD
Sunitinib—RPS6KB1—adrenal gland—adrenal gland cancer	0.000168	0.00171	CbGeAlD
Sunitinib—RET—adrenal gland—adrenal gland cancer	0.000167	0.0017	CbGeAlD
Sunitinib—FGR—adrenal gland—adrenal gland cancer	0.000167	0.0017	CbGeAlD
Sunitinib—EPHB6—cardiac atrium—adrenal gland cancer	0.000166	0.0017	CbGeAlD
Sunitinib—AXL—adrenal gland—adrenal gland cancer	0.000166	0.00169	CbGeAlD
Sunitinib—FLT1—pituitary gland—adrenal gland cancer	0.000164	0.00168	CbGeAlD
Sunitinib—EPHB6—pituitary gland—adrenal gland cancer	0.000162	0.00166	CbGeAlD
Sunitinib—YES1—gonad—adrenal gland cancer	0.000161	0.00164	CbGeAlD
Sunitinib—YES1—cardiac atrium—adrenal gland cancer	0.000161	0.00164	CbGeAlD
Sunitinib—SLK—adrenal gland—adrenal gland cancer	0.00016	0.00163	CbGeAlD
Sunitinib—STK10—gonad—adrenal gland cancer	0.000159	0.00163	CbGeAlD
Sunitinib—TAOK3—cardiac atrium—adrenal gland cancer	0.000159	0.00162	CbGeAlD
Sunitinib—FGFR2—adrenal gland—adrenal gland cancer	0.000158	0.00162	CbGeAlD
Sunitinib—PDGFRA—gonad—adrenal gland cancer	0.000158	0.00161	CbGeAlD
Sunitinib—JAK2—adrenal gland—adrenal gland cancer	0.000157	0.00161	CbGeAlD
Sunitinib—YES1—pituitary gland—adrenal gland cancer	0.000157	0.0016	CbGeAlD
Sunitinib—FYN—adrenal gland—adrenal gland cancer	0.000155	0.00159	CbGeAlD
Sunitinib—TAOK3—pituitary gland—adrenal gland cancer	0.000155	0.00158	CbGeAlD
Sunitinib—MAP4K5—adrenal gland—adrenal gland cancer	0.000152	0.00155	CbGeAlD
Sunitinib—MAP3K3—adrenal gland—adrenal gland cancer	0.000152	0.00155	CbGeAlD
Sunitinib—PDGFRB—adrenal cortex—adrenal gland cancer	0.000149	0.00152	CbGeAlD
Sunitinib—FLT1—adrenal gland—adrenal gland cancer	0.000147	0.0015	CbGeAlD
Sunitinib—EPHB6—adrenal gland—adrenal gland cancer	0.000145	0.00148	CbGeAlD
Sunitinib—KDR—cardiac atrium—adrenal gland cancer	0.000142	0.00145	CbGeAlD
Sunitinib—MAP2K5—cardiac atrium—adrenal gland cancer	0.000142	0.00145	CbGeAlD
Sunitinib—YES1—adrenal gland—adrenal gland cancer	0.00014	0.00143	CbGeAlD
Sunitinib—STK10—adrenal gland—adrenal gland cancer	0.000139	0.00142	CbGeAlD
Sunitinib—CSF1R—gonad—adrenal gland cancer	0.000139	0.00142	CbGeAlD
Sunitinib—MAP2K5—pituitary gland—adrenal gland cancer	0.000139	0.00142	CbGeAlD
Sunitinib—KDR—pituitary gland—adrenal gland cancer	0.000139	0.00142	CbGeAlD
Sunitinib—CSF1R—cardiac atrium—adrenal gland cancer	0.000139	0.00142	CbGeAlD
Sunitinib—TAOK3—adrenal gland—adrenal gland cancer	0.000138	0.00141	CbGeAlD
Sunitinib—PDGFRA—adrenal gland—adrenal gland cancer	0.000137	0.0014	CbGeAlD
Sunitinib—CSF1R—pituitary gland—adrenal gland cancer	0.000136	0.00138	CbGeAlD
Sunitinib—KIT—gonad—adrenal gland cancer	0.000126	0.00129	CbGeAlD
Sunitinib—MAP2K5—adrenal gland—adrenal gland cancer	0.000124	0.00127	CbGeAlD
Sunitinib—KDR—adrenal gland—adrenal gland cancer	0.000124	0.00127	CbGeAlD
Sunitinib—PDGFRB—gonad—adrenal gland cancer	0.000123	0.00126	CbGeAlD
Sunitinib—KIT—pituitary gland—adrenal gland cancer	0.000123	0.00126	CbGeAlD
Sunitinib—PDGFRB—cardiac atrium—adrenal gland cancer	0.000123	0.00126	CbGeAlD
Sunitinib—CSF1R—adrenal gland—adrenal gland cancer	0.000121	0.00124	CbGeAlD
Sunitinib—PDGFRB—pituitary gland—adrenal gland cancer	0.00012	0.00123	CbGeAlD
Sunitinib—KIT—adrenal gland—adrenal gland cancer	0.00011	0.00112	CbGeAlD
Sunitinib—PDGFRB—adrenal gland—adrenal gland cancer	0.000107	0.0011	CbGeAlD
Sunitinib—ABCC4—adrenal gland—adrenal gland cancer	8.55e-05	0.000873	CbGeAlD
Sunitinib—ABCG2—adrenal cortex—adrenal gland cancer	8.36e-05	0.000853	CbGeAlD
Sunitinib—ABCC2—adrenal gland—adrenal gland cancer	8.27e-05	0.000845	CbGeAlD
Sunitinib—KCNH2—cardiac atrium—adrenal gland cancer	7.77e-05	0.000794	CbGeAlD
Sunitinib—KCNH2—pituitary gland—adrenal gland cancer	7.59e-05	0.000775	CbGeAlD
Sunitinib—KCNH2—adrenal gland—adrenal gland cancer	6.78e-05	0.000693	CbGeAlD
Sunitinib—ABCG2—pituitary gland—adrenal gland cancer	6.75e-05	0.00069	CbGeAlD
Sunitinib—ABCG2—adrenal gland—adrenal gland cancer	6.03e-05	0.000616	CbGeAlD
Sunitinib—ABCB1—adrenal cortex—adrenal gland cancer	4.12e-05	0.000421	CbGeAlD
Sunitinib—ABCB1—gonad—adrenal gland cancer	3.41e-05	0.000349	CbGeAlD
Sunitinib—ABCB1—pituitary gland—adrenal gland cancer	3.33e-05	0.00034	CbGeAlD
Sunitinib—ABCB1—adrenal gland—adrenal gland cancer	2.98e-05	0.000304	CbGeAlD
Sunitinib—KDR—Signaling Pathways—BRAF—adrenal gland cancer	2.62e-06	1.89e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—BAD—adrenal gland cancer	2.61e-06	1.89e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CDC42—adrenal gland cancer	2.61e-06	1.89e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TERT—adrenal gland cancer	2.61e-06	1.88e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—GNAS—adrenal gland cancer	2.6e-06	1.88e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—BAD—adrenal gland cancer	2.6e-06	1.88e-05	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—TP53—adrenal gland cancer	2.6e-06	1.88e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IGF1R—adrenal gland cancer	2.6e-06	1.88e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—EGFR—adrenal gland cancer	2.56e-06	1.85e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TERT—adrenal gland cancer	2.56e-06	1.85e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TERT—adrenal gland cancer	2.56e-06	1.85e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—EGFR—adrenal gland cancer	2.55e-06	1.84e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—CTNNB1—adrenal gland cancer	2.54e-06	1.83e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IGF1R—adrenal gland cancer	2.54e-06	1.83e-05	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—EGFR—adrenal gland cancer	2.53e-06	1.83e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—TP53—adrenal gland cancer	2.53e-06	1.83e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—TP53—adrenal gland cancer	2.53e-06	1.83e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—BRAF—adrenal gland cancer	2.53e-06	1.83e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IGF2—adrenal gland cancer	2.53e-06	1.83e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—EGFR—adrenal gland cancer	2.53e-06	1.82e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—EGFR—adrenal gland cancer	2.53e-06	1.82e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—EGFR—adrenal gland cancer	2.52e-06	1.82e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IGF2—adrenal gland cancer	2.52e-06	1.82e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—GNAS—adrenal gland cancer	2.51e-06	1.81e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—EGFR—adrenal gland cancer	2.5e-06	1.81e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—BAD—adrenal gland cancer	2.49e-06	1.8e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CDC42—adrenal gland cancer	2.49e-06	1.8e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—GNAS—adrenal gland cancer	2.49e-06	1.8e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—EGFR—adrenal gland cancer	2.49e-06	1.8e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—BAD—adrenal gland cancer	2.49e-06	1.8e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—BRAF—adrenal gland cancer	2.47e-06	1.78e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—TP53—adrenal gland cancer	2.46e-06	1.77e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—CTNNB1—adrenal gland cancer	2.45e-06	1.77e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IGF1R—adrenal gland cancer	2.45e-06	1.77e-05	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—EGFR—adrenal gland cancer	2.43e-06	1.76e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IGF1R—adrenal gland cancer	2.43e-06	1.76e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TERT—adrenal gland cancer	2.43e-06	1.76e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TERT—adrenal gland cancer	2.42e-06	1.75e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—GNAS—adrenal gland cancer	2.42e-06	1.75e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—PTGS2—adrenal gland cancer	2.41e-06	1.74e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—EGFR—adrenal gland cancer	2.41e-06	1.74e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CTNNB1—adrenal gland cancer	2.41e-06	1.74e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—EGFR—adrenal gland cancer	2.41e-06	1.74e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IGF2—adrenal gland cancer	2.4e-06	1.74e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—GNAS—adrenal gland cancer	2.4e-06	1.73e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—GNAS—adrenal gland cancer	2.38e-06	1.72e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—PTGS2—adrenal gland cancer	2.38e-06	1.72e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—BRAF—adrenal gland cancer	2.38e-06	1.72e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—ABCB1—adrenal gland cancer	2.37e-06	1.71e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—BRAF—adrenal gland cancer	2.37e-06	1.71e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—BAD—adrenal gland cancer	2.37e-06	1.71e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—TP53—adrenal gland cancer	2.36e-06	1.71e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	2.35e-06	1.7e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—PTGS2—adrenal gland cancer	2.34e-06	1.69e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CTNNB1—adrenal gland cancer	2.34e-06	1.69e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IGF1R—adrenal gland cancer	2.32e-06	1.68e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CTNNB1—adrenal gland cancer	2.31e-06	1.67e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.3e-06	1.66e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—POMC—adrenal gland cancer	2.3e-06	1.66e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—BAD—adrenal gland cancer	2.3e-06	1.66e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—CTNNB1—adrenal gland cancer	2.28e-06	1.65e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—BRAF—adrenal gland cancer	2.27e-06	1.64e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—EGFR—adrenal gland cancer	2.27e-06	1.64e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—BAD—adrenal gland cancer	2.27e-06	1.64e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CTNNB1—adrenal gland cancer	2.27e-06	1.64e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—CTNNB1—adrenal gland cancer	2.27e-06	1.64e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—TP53—adrenal gland cancer	2.27e-06	1.64e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—BRAF—adrenal gland cancer	2.26e-06	1.64e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—EGFR—adrenal gland cancer	2.25e-06	1.63e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.25e-06	1.62e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—TP53—adrenal gland cancer	2.25e-06	1.62e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TERT—adrenal gland cancer	2.24e-06	1.62e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—BAD—adrenal gland cancer	2.23e-06	1.61e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—BAD—adrenal gland cancer	2.23e-06	1.61e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PTGS2—adrenal gland cancer	2.22e-06	1.6e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PTGS2—adrenal gland cancer	2.21e-06	1.6e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MED12—adrenal gland cancer	2.21e-06	1.6e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TERT—adrenal gland cancer	2.18e-06	1.58e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—POMC—adrenal gland cancer	2.18e-06	1.58e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—CTNNB1—adrenal gland cancer	2.16e-06	1.56e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—BRAF—adrenal gland cancer	2.15e-06	1.56e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CTNNB1—adrenal gland cancer	2.15e-06	1.55e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CTNNB1—adrenal gland cancer	2.15e-06	1.55e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—TP53—adrenal gland cancer	2.14e-06	1.55e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	2.14e-06	1.54e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—CTNNB1—adrenal gland cancer	2.13e-06	1.54e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—TP53—adrenal gland cancer	2.12e-06	1.53e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—POMC—adrenal gland cancer	2.12e-06	1.53e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—BAD—adrenal gland cancer	2.11e-06	1.53e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—BAD—adrenal gland cancer	2.11e-06	1.52e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TERT—adrenal gland cancer	2.1e-06	1.52e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TERT—adrenal gland cancer	2.09e-06	1.51e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—CTNNB1—adrenal gland cancer	2.09e-06	1.51e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—POMC—adrenal gland cancer	2.09e-06	1.51e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—BRAF—adrenal gland cancer	2.09e-06	1.51e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.09e-06	1.51e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—BRAF—adrenal gland cancer	2.06e-06	1.49e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—POMC—adrenal gland cancer	2.05e-06	1.48e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—POMC—adrenal gland cancer	2.05e-06	1.48e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PTGS2—adrenal gland cancer	2.04e-06	1.48e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—BRAF—adrenal gland cancer	2.03e-06	1.47e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—BRAF—adrenal gland cancer	2.03e-06	1.47e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—EGFR—adrenal gland cancer	2.03e-06	1.46e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TP53—adrenal gland cancer	2.02e-06	1.46e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.01e-06	1.45e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—EGFR—adrenal gland cancer	2.01e-06	1.45e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TERT—adrenal gland cancer	2e-06	1.45e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	2e-06	1.45e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PTGS2—adrenal gland cancer	1.99e-06	1.44e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—CTNNB1—adrenal gland cancer	1.99e-06	1.44e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—CTNNB1—adrenal gland cancer	1.98e-06	1.43e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CTNNB1—adrenal gland cancer	1.98e-06	1.43e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—POMC—adrenal gland cancer	1.95e-06	1.41e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—BAD—adrenal gland cancer	1.95e-06	1.41e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—EGFR—adrenal gland cancer	1.94e-06	1.4e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—POMC—adrenal gland cancer	1.94e-06	1.4e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.94e-06	1.4e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—CTNNB1—adrenal gland cancer	1.94e-06	1.4e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CTNNB1—adrenal gland cancer	1.93e-06	1.4e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—BRAF—adrenal gland cancer	1.92e-06	1.39e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—PTGS2—adrenal gland cancer	1.92e-06	1.39e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—BRAF—adrenal gland cancer	1.92e-06	1.39e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PTGS2—adrenal gland cancer	1.91e-06	1.38e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—EGFR—adrenal gland cancer	1.91e-06	1.38e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TP53—adrenal gland cancer	1.9e-06	1.38e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—BAD—adrenal gland cancer	1.9e-06	1.37e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CTNNB1—adrenal gland cancer	1.89e-06	1.37e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—adrenal gland cancer	1.89e-06	1.37e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CTNNB1—adrenal gland cancer	1.86e-06	1.35e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CTNNB1—adrenal gland cancer	1.85e-06	1.34e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—EGFR—adrenal gland cancer	1.85e-06	1.34e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—BAD—adrenal gland cancer	1.83e-06	1.32e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—CTNNB1—adrenal gland cancer	1.83e-06	1.32e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—EGFR—adrenal gland cancer	1.83e-06	1.32e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—PTGS2—adrenal gland cancer	1.83e-06	1.32e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.83e-06	1.32e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.83e-06	1.32e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—EGFR—adrenal gland cancer	1.82e-06	1.32e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—BAD—adrenal gland cancer	1.82e-06	1.32e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—EGFR—adrenal gland cancer	1.81e-06	1.31e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—EGFR—adrenal gland cancer	1.8e-06	1.3e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—EGFR—adrenal gland cancer	1.8e-06	1.3e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—POMC—adrenal gland cancer	1.79e-06	1.3e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—CTNNB1—adrenal gland cancer	1.78e-06	1.29e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—BRAF—adrenal gland cancer	1.77e-06	1.28e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CTNNB1—adrenal gland cancer	1.77e-06	1.28e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—POMC—adrenal gland cancer	1.75e-06	1.27e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—BAD—adrenal gland cancer	1.74e-06	1.26e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GNAS—adrenal gland cancer	1.73e-06	1.25e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—BRAF—adrenal gland cancer	1.73e-06	1.25e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—CTNNB1—adrenal gland cancer	1.72e-06	1.24e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—EGFR—adrenal gland cancer	1.72e-06	1.24e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—CTNNB1—adrenal gland cancer	1.71e-06	1.24e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—EGFR—adrenal gland cancer	1.71e-06	1.24e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—EGFR—adrenal gland cancer	1.7e-06	1.23e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	1.7e-06	1.23e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—EGFR—adrenal gland cancer	1.7e-06	1.23e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—EGFR—adrenal gland cancer	1.69e-06	1.22e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—POMC—adrenal gland cancer	1.69e-06	1.22e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—POMC—adrenal gland cancer	1.68e-06	1.21e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—BRAF—adrenal gland cancer	1.67e-06	1.2e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—EGFR—adrenal gland cancer	1.66e-06	1.2e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—BRAF—adrenal gland cancer	1.66e-06	1.2e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—EGFR—adrenal gland cancer	1.66e-06	1.2e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.64e-06	1.19e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—CTNNB1—adrenal gland cancer	1.64e-06	1.18e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—adrenal gland cancer	1.63e-06	1.18e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—POMC—adrenal gland cancer	1.63e-06	1.18e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—POMC—adrenal gland cancer	1.61e-06	1.17e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.61e-06	1.17e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—EGFR—adrenal gland cancer	1.61e-06	1.16e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—POMC—adrenal gland cancer	1.6e-06	1.16e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—EGFR—adrenal gland cancer	1.59e-06	1.15e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—EGFR—adrenal gland cancer	1.58e-06	1.15e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—BRAF—adrenal gland cancer	1.58e-06	1.15e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—EGFR—adrenal gland cancer	1.57e-06	1.14e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—EGFR—adrenal gland cancer	1.57e-06	1.13e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—EGFR—adrenal gland cancer	1.57e-06	1.13e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.56e-06	1.12e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—EGFR—adrenal gland cancer	1.54e-06	1.11e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—EGFR—adrenal gland cancer	1.54e-06	1.11e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—EGFR—adrenal gland cancer	1.54e-06	1.11e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—EGFR—adrenal gland cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—adrenal gland cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—adrenal gland cancer	1.52e-06	1.1e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.51e-06	1.09e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—EGFR—adrenal gland cancer	1.5e-06	1.08e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.49e-06	1.08e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—EGFR—adrenal gland cancer	1.48e-06	1.07e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—EGFR—adrenal gland cancer	1.47e-06	1.06e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CTNNB1—adrenal gland cancer	1.47e-06	1.06e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CTNNB1—adrenal gland cancer	1.47e-06	1.06e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—EGFR—adrenal gland cancer	1.45e-06	1.05e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—EGFR—adrenal gland cancer	1.41e-06	1.02e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—EGFR—adrenal gland cancer	1.4e-06	1.01e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.39e-06	1.01e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—adrenal gland cancer	1.39e-06	1e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CTNNB1—adrenal gland cancer	1.39e-06	1e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—EGFR—adrenal gland cancer	1.36e-06	9.85e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.36e-06	9.85e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EGFR—adrenal gland cancer	1.36e-06	9.8e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—adrenal gland cancer	1.34e-06	9.68e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—adrenal gland cancer	1.33e-06	9.61e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.31e-06	9.45e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EGFR—adrenal gland cancer	1.3e-06	9.4e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—adrenal gland cancer	1.3e-06	9.39e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—EGFR—adrenal gland cancer	1.3e-06	9.36e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—adrenal gland cancer	1.29e-06	9.32e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—adrenal gland cancer	1.29e-06	9.32e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	1.29e-06	9.3e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.28e-06	9.26e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—adrenal gland cancer	1.26e-06	9.09e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CTNNB1—adrenal gland cancer	1.25e-06	9.03e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EGFR—adrenal gland cancer	1.23e-06	8.91e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CTNNB1—adrenal gland cancer	1.2e-06	8.71e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.2e-06	8.66e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EGFR—adrenal gland cancer	1.2e-06	8.65e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EGFR—adrenal gland cancer	1.18e-06	8.54e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—POMC—adrenal gland cancer	1.17e-06	8.43e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EGFR—adrenal gland cancer	1.16e-06	8.39e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EGFR—adrenal gland cancer	1.16e-06	8.39e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.15e-06	8.28e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EGFR—adrenal gland cancer	1.1e-06	7.96e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EGFR—adrenal gland cancer	1.1e-06	7.94e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—adrenal gland cancer	1.09e-06	7.89e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—adrenal gland cancer	1.04e-06	7.48e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EGFR—adrenal gland cancer	1.01e-06	7.33e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—adrenal gland cancer	1.01e-06	7.26e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	9.94e-07	7.18e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—adrenal gland cancer	9.93e-07	7.17e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EGFR—adrenal gland cancer	9.9e-07	7.16e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—adrenal gland cancer	9.75e-07	7.05e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—adrenal gland cancer	9.75e-07	7.05e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EGFR—adrenal gland cancer	9.54e-07	6.9e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EGFR—adrenal gland cancer	9.49e-07	6.86e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	9.31e-07	6.72e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—adrenal gland cancer	9.25e-07	6.69e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—adrenal gland cancer	9.23e-07	6.67e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EGFR—adrenal gland cancer	9.07e-07	6.56e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—POMC—adrenal gland cancer	8.8e-07	6.36e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—adrenal gland cancer	8.52e-07	6.16e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—adrenal gland cancer	8.31e-07	6.01e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GNAS—adrenal gland cancer	8.06e-07	5.82e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—adrenal gland cancer	8.01e-07	5.79e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—adrenal gland cancer	7.97e-07	5.76e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	7.9e-07	5.71e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—adrenal gland cancer	7.62e-07	5.5e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—adrenal gland cancer	7.02e-07	5.07e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—POMC—adrenal gland cancer	5.42e-07	3.92e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4.33e-07	3.13e-06	CbGpPWpGaD
